EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

PURPOSE: The EML4-ALK fusion gene has been detected in ~7% of Japanese non-small cell lung cancers (NSCLC). We determined the frequency of EML4-ALK in Caucasian NSCLCs and in NSCLC cell lines. We also determined whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK co...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Koivunen, Jussi P., Mermel, Craig, Zejnullahu, Kreshnik, Murphy, Carly, Lifshits, Eugene, Holmes, Alison J., Choi, Hwan Geun, Kim, Jhingook, Chiang, Derek, Thomas, Roman, Lee, Jinseon, Richards, William G., Sugarbaker, David J., Ducko, Christopher, Lindeman, Neal, Marcoux, J. Paul, Engelman, Jeffrey A., Gray, Nathanael S., Lee, Charles, Meyerson, Matthew, Jänne, Pasi A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3025451/
https://ncbi.nlm.nih.gov/pubmed/18594010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0168
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg